CURTIS GEOFFREY M. 4
4 · Horizon Therapeutics Public Ltd Co · Filed Apr 2, 2021
Insider Transaction Report
Form 4
CURTIS GEOFFREY M.
SVP, Corporate Communications
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-04-01−20,000→ 0 totalExercise: $29.22Exp: 2025-05-01→ Ordinary Shares (20,000 underlying) - Exercise/Conversion
Ordinary Shares
2021-04-01$29.22/sh+20,000$584,400→ 123,414 total - Exercise/Conversion
Ordinary Shares
2021-04-01$27.43/sh+17,000$466,310→ 103,414 total - Sale
Ordinary Shares
2021-04-01$93.51/sh−70,739$6,615,094→ 52,675 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-01−17,000→ 0 totalExercise: $27.43Exp: 2025-04-08→ Ordinary Shares (17,000 underlying)
Holdings
- 420(indirect: By Spouse)
Ordinary Shares
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2021.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.51 to $93.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The stock option is fully vested and exercisable.